ID SOLUTIONS

👀 What you don’t see behind every reliable results.   In front of every analysis, every pieces of data, every decisions… There’s a crucial step that’s often overlooked: development.   This month, we’re shining a spotlight on our Development team.   Turning an idea into a concrete solution Testing, adjusting, validating Producing with rigor and consistency   Precision work, where every detail counts. Work that is often invisible, but mandatory.   Because in molecular diagnostics, reliability cannot be improvised. It is built, step by step. Daniel Henaff Johanna BARLETTA Victoria Horat Margot Bichon Emaëlle ARTUS Manon Herve Mathieu Garcia Mathias RIEGER

ID SOLUTIONS sera présent à BIOMED-J 2026. Les 28 et 29 mai, retrouvez notre équipe au congrès BIOMED-J, un rendez-vous dédié aux acteurs du diagnostic et de la biologie médicale.   À cette occasion, Oscar Lenguas, Deborah Santangelo et Christophe Carpentieri représenteront ID SOLUTIONS pour échanger autour des enjeux actuels du diagnostic moléculaire.   Nous serons également présents aux côtés de notre partenaire Sansure Biotech Inc..   Ce sera l’occasion de discuter des évolutions du diagnostic en oncologie et en infectiologie, et de partager nos perspectives sur les technologies PCR digitale et quantitative.   Vous serez présents ? Venez nous rencontrer au stand 50 !    📅 28–29 mai 2026 📍 Palais des Congrès de Paris – Porte Maillot 📍 STAND 50

👀 Expertise is not just related to improved technology and accessibility. Like in sport, it builds over time with practice.   “Our mission is to stimulate new ideas and technologies, to facilitate patient access to a faster, more affordable, precision medical diagnostics. We strive to offer cutting edge solutions with real impact.” said Lise GREWIS 🚀 At ID SOLUTIONS, we believe molecular diagnostics should not stay confined to theory or performance claims but have a real impact in real laboratory live conditions.   It must work. In real laboratories. Under real conditions. With real samples.   From the beginning of our journey, we have been developing and supporting digital PCR (dPCR) and quantitative PCR (qPCR) solutions designed for everyday use in oncology and infectious disease laboratories.   Our approach is built on four key pillars: 1. Technological expertise you can rely on. 2. A deep understanding of laboratory workflows and challenges. 3. Close scientific and technical support. 4. A vision aligned with precision medicine.   Our mission remains unchanged: Turning scientific innovation into practical, reliable solutions for laboratories and their patients.

Understanding the risk, is the first step toward better treatment.   Worldwide, tobacco causes more than 7 million deaths each year. Even after quitting, the risk of lung cancer is still there, only decreasing gradually over time. This risk drops to 50% after 10 years of abstinence.   Lung cancer is a complex disease, which often develops over several years. And most importantly, not all lung cancers are the same.   Behind a single diagnosis, there are, in fact, several biological profiles, linked to specific mutations such as EGFR, KRAS, or BRAF.   These mutations influence: the progression of the disease the response to treatments the treatment options available   Today, approaches are evolving. We no longer simply detect cancer. We seek to understand it in depth.   Identify conditions more quickly to provide treatment as early as possible—treatment that is more appropriate and more effective.   Because in oncology, the right diagnosis and the right associated treatment at the right time can change everything.

𝗜𝗗 𝗦𝗢𝗟𝗨𝗧𝗜𝗢𝗡𝗦 “𝗚𝗲𝘁 𝗶𝗻 𝗚𝗲𝗮𝗿” 𝗼𝗻 𝗺𝗲𝘁𝗵𝘆𝗹𝗮𝘁𝗶𝗼𝗻 Methylation is entering a new era. With our single-well enzymatic approach, ID SOLUTIONS is simplifying and modernising epigenetic analysis via dPCR—removing cumbersome steps while preserving direct quantification and analytical robustness. But beyond simplification, one key challenge remains in methylation analysis: control and reliability of the signal. 𝗜𝗗 𝗦𝗢𝗟𝗨𝗧𝗜𝗢𝗡𝗦 𝗶𝘀 𝘁𝗮𝗸𝗶𝗻𝗴 𝗮 𝗻𝗲𝘄 𝘀𝘁𝗲𝗽 𝗳𝗼𝗿𝘄𝗮𝗿𝗱.   Our solution for the detection and quantification of MGMT promoter methylation is now available on the QX200 and QX600, and 𝘄𝗶𝗹𝗹 𝘀𝗼𝗼𝗻 𝗯𝗲 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲 on the Digital LightCycler. Meanwhile, our MLH1 kit is already: ✅ Available on the Digital LightCycler as part of the 𝗜𝗗𝗢𝗡𝗧𝗥𝗔𝗫 𝗿𝗮𝗻𝗴𝗲 ✅ Available on the QX200 and QX600 as part of the 𝗜𝗗𝗘𝗡𝗧𝗜𝗙𝗬 𝗿𝗮𝗻𝗴𝗲 Two strategic targets, one shared ambition: 𝘁𝗼 𝗺𝗮𝗸𝗲 𝗺𝗲𝘁𝗵𝘆𝗹𝗮𝘁𝗶𝗼𝗻 𝗮𝗰𝗰𝗲𝘀𝘀𝗶𝗯𝗹𝗲, 𝗿𝗼𝗯𝘂𝘀𝘁 𝗮𝗻𝗱 𝗾𝘂𝗮𝗻𝘁𝗶𝘁𝗮𝘁𝗶𝘃𝗲 𝗶𝗻 𝗱𝗣𝗖𝗥. Our solutions feature: ✔️ A simplified workflow ✔️ A bisulphite-free approach ✔️ Internal controls to ensure analytical performance   𝗙𝗼𝗿 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗨𝘀𝗲 𝗢𝗻𝗹𝘆 (𝗥𝗨𝗢). These products are not intended for diagnostic use or clinical decision.

Heading to AACR 2026 in San Diego! 🌴 From April 17 to 22, AACR Annual Meeting will bring together the global oncology research community at the San Diego Convention Center, California. On this occasion, Damien MAGNEE, International Sales Director, and Daniel Henaff, Scientific Director, will be on site representing ID SOLUTIONS. AACR is a key moment to explore the latest advances in cancer research and to exchange with experts shaping the future of oncology. If you are attending, this is a great opportunity to connect and discuss how molecular diagnostics can support research and precision medicine approaches. 📍 San Diego Convention Center, USA 📅 April 17–22, 2026 Feel free to reach out to schedule a meeting 😊 American Association for Cancer Research

What if science were explained in simple terms?   To mark World Health Day 2026, organized by the World Health Organization, we launched an internal initiative centered on one question: How does science improve your life?   Everyone took a few moments to answer it. A word, a sentence, an idea. Then they shared it on a Post-it note, stuck to a dedicated wall.   Personal, spontaneous, diverse answers… which, when put together, paint a collective vision.   This wall has become much more than a simple display: it embodies what unites us around science and health.   Because behind every contribution lies a reality: science guides decisions it enables reliable diagnoses it tangibly improves patient care   Through this initiative, they take shape. They become visible, understandable, shared.   This is also the essence of the 2026 campaign: “Stand with Science”   Because health is a collective effort. And every contribution, no matter how simple, plays a part.   👉 And for you, how does science improve your life?

As part of the 8th 𝗙𝗿𝗲𝗻𝗰𝗵-𝗚𝗲𝗿𝗺𝗮𝗻 𝗙𝗼𝗿𝘁𝗻𝗶𝗴𝗵𝘁 𝗶𝗻 𝗢𝗰𝗰𝗶𝘁𝗮𝗻𝗶𝗲, ID SOLUTIONS is proud to support the conference: "𝗟𝗶𝗾𝘂𝗶𝗱 𝗕𝗶𝗼𝗽𝘀𝘆 & 𝗪𝗼𝗺𝗲𝗻 𝗦𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀: 𝗙𝗿𝗲𝗻𝗰𝗵-𝗚𝗲𝗿𝗺𝗮𝗻 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻𝘀 𝗶𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆."   Liquid biopsy is establishing itself as a strategic pillar in transforming cancer diagnosis and patient monitoring—making it faster, more sensitive, and more accessible.   Within this movement, a new generation of leadership is emerging 𝘄𝗼𝗺𝗲𝗻 𝘀𝗰𝗶𝗲𝗻𝘁𝗶𝘀𝘁𝘀 𝗮𝗻𝗱 𝗲𝘅𝗲𝗰𝘂𝘁𝗶𝘃𝗲𝘀 𝘄𝗵𝗼 𝗮𝗿𝗲 𝗱𝗿𝗶𝘃𝗶𝗻𝗴 𝗮𝗺𝗯𝗶𝘁𝗶𝗼𝘂𝘀 𝘃𝗶𝘀𝗶𝗼𝗻𝘀, 𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗶𝗻𝗴 𝗶𝗻𝘁𝗲𝗿𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗹𝗹𝗮𝗯𝗼𝗿𝗮𝘁𝗶𝗼𝗻𝘀, 𝗮𝗻𝗱 𝗮𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗶𝗻𝗴 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗯𝗿𝗲𝗮𝗸𝘁𝗵𝗿𝗼𝘂𝗴𝗵.   This morning session will be a unique opportunity to: 🔹𝗗𝗲𝗰𝗼𝗱𝗲 key advances in liquid biopsy. 🔹𝗦𝗵𝗮𝗿𝗲 concrete perspectives between French and German experts. 🔹𝗦𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 high-impact European synergies in healthcare.   📍 EVENT DETAILS 📅 April 13, 2026 | 08:30 AM – 2:00 PM 📍 Domaine de Verchant, Castelnau-le-Lez (France) 🎟 Free event – Registration is mandatory 👉 Register here : https://lnkd.in/driQs4wb   Catherine Alix-Panabières I Anne FERRER-VILLENEUVE I Emmanuelle Garnier I Recherche et innovation – CHU de Montpellier I Renan Targhetta I LINDA GIMENO I Pôle Biologie Pathologie du CHU de Montpellier I Laurence LACHAUD I Jean-Paul Cristol I Liquid Biopsy LCCRH Lab - Laboratoire Cellules Circulantes Rares Humaines I Isabelle Laffont I Faculté de Médecine Montpellier-Nîmes I Prof. Sonja Loges MD, PhD I Universität Heidelberg I Laura Keller I Jean-Pierre DELORD, MD, PhD I IUCT-Oncopole I Klaus Pantel I Universität Hamburg I Montpellier, Ville, Métropole et CCAS I Michaël Delafosse I Philippe Augé I Université de Montpellier I Patrick PARIS I Michel Robert I Lucie Lecherbonnier I SIRIC Montpellier Cancer I ICM - Institut du Cancer de Montpellier I MedVallée Montpellier I Lise GREWIS I Damien MAGNEE I Daniel Henaff I Richard JARRY I CERBA HEALTHCARE I Aurelie Driss-Corbin I European Liquid Biopsy Society Admin I DKFZ German Cancer Research Center I Michael Baumann I Association Allemagne-Occitanie – L’Europe au cœur

Heading to Munich for ESCMID 2026!   From April 17th to 21st, the ESCMID Global Congress will bring together the international infectious disease and clinical microbiology community.   Oscar Lenguas, Director for Science Innovation and Technology at ID SOLUTIONS, will be in Munich for the event to learn about the latest scientific advances, talk with industry players and follow up with partners.   If you are also attending the congress, this will be an excellent opportunity to meet and discuss current trends in molecular diagnostics and infectious diseases.   📍 Munich, Messe Munich Exhibition & Congress Center 📅 April 17–21, 2026   Feel free to contact us to arrange a meeting on site! ESCMID - European Society of Clinical Microbiology and Infectious Diseases

“WE DO NOT JUST DO DIAGNOSTICS” At ID SOLUTIONS, we started with a simple belief: Applications are only valuable if they are reliable, standardized, and truly usable in the field. 📖 Since our creation, we have been developing molecular diagnostic solutions in oncology and infectious diseases with one constant requirement: “Does it make science more accessible to laboratories without compromising on accuracy?” 🇫🇷 We are an independent French company, driven by a team of scientific, technical, quality and commercial experts with a clear vision: “Bridging the gap between technological innovation and practical applications” Our role is not just to offer tests. Our role is to support laboratories in their daily challenges: •   performance, •   reliability, •   standardization, •   regulatory compliance, •   and ever-changing practices. We believe in an approach where scientific excellence meets the reality of the field: Our customers and their patients. Where innovation does not bypass rigorous requirements but reinforces it. If you are discovering ID SOLUTIONS today, welcome in our mission. And if you already know us, you know that our commitment is not limited to words. Precision diagnostics are built on high standards. And we are proud to contribute to this. https://lnkd.in/enANReqe